Bleeding profile of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 μg compared to a 21-day regimen.

被引：0
|
作者：
Ellman, H
Archer, DF
机构：
[1] Warner Chilcott, Rockaway, NJ USA
[2] CONRAD Clin Res Ctr, Norfolk, VA USA
来源：
FERTILITY AND STERILITY | 2005年 / 84卷
关键词：
D O I：
10.1016/j.fertnstert.2005.07.423
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S171 / S171
页数：1
相关论文
共 33 条
  • [1] Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 μg given for 24 days compared to a 21-day regimen.
    Ellman, H
    Archer, DF
    [J]. FERTILITY AND STERILITY, 2005, 84 : S169 - S170
  • [2] Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 μg (Loestrin® 24 Fe)
    Nakajima, Steven T.
    Archer, David F.
    Ellman, Herman
    [J]. CONTRACEPTION, 2007, 75 (01) : 16 - 22
  • [3] Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activity
    Sullivan, H
    Furniss, H
    Spona, J
    Elstein, M
    [J]. FERTILITY AND STERILITY, 1999, 72 (01) : 115 - 120
  • [4] Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 20 μg ethinyl estradiol and 150 μg desogestrel
    Endrikat, J
    Cronin, M
    Gerlinger, C
    Ruebig, A
    Schmidt, W
    Düsterberg, B
    [J]. CONTRACEPTION, 2001, 64 (03) : 201 - 207
  • [5] Cycle control, safety and efficacy of a 24-day regimen of gestodene 60 μg/ethinylestradiol 15 μg and a 21-day regimen of desogestrel 150 μg/ethinylestradiol 20 μg
    Affronti, G.
    Spiclinann, D.
    Ambrosini, A.
    Bocci, A.
    Campogrande, M.
    Dodero, D.
    Flamigni, C.
    Giardina, G.
    Litta, P.
    Massobrio, M.
    Scarselli, G.
    Meriggi, E.
    Pauwels, C. P.
    DeBruyn, M.
    Gerris, J.
    Nolens, J. P.
    Blanchere, J. P.
    Bernard-Besnoit, A.
    Bilhaut, J. P.
    Coudray, J.
    Guigues, B.
    Jolly, C.
    Maupain, M.
    Hieu, N. Nguyen
    Amadio, E.
    Dalbos, D.
    De Granvilliers, M. A.
    Devaure, Y.
    De Vedrine, C. H.
    Dress, M. M.
    Guibert, L.
    Hazane, J. C.
    Kern, A. M.
    Levrier, M.
    Malgouyat, J.
    Mallet, F.
    Marteau, C.
    Safayan, A.
    Sentenac, J.
    De Boer, R.
    Van Enk, A.
    Mattheussens, O. J. A.
    The, H. S.
    Ypma, T. J. D.
    Rickli, J. P.
    Florek, E.
    Stadlin, M.
    Bitzer, J.
    Brunclik, V.
    Grueter, J.
    [J]. EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 1999, 4 : 17 - 25
  • [6] Cycle Control With a 21-Day Compared With a 24-Day Oral Contraceptive Pill: A Randomized Controlled Trial
    Richman, Susan
    [J]. OBSTETRICS AND GYNECOLOGY, 2010, 115 (04): : 866 - 867
  • [7] Cycle Control With a 21-Day Compared With a 24-Day Oral Contraceptive Pill A Randomized Controlled Trial
    Kaunitz, Andrew M.
    Burkman, Ronald T.
    Fisher, Alan C.
    LaGuardia, Katherine D.
    [J]. OBSTETRICS AND GYNECOLOGY, 2009, 114 (06): : 1205 - 1212
  • [8] A double-blind comparative study of the effects of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 30 μg ethinyl estradiol and 75 μg gestodene on hemostatic variables, lipids, and carbohydrate metabolism
    Endrikat, J
    Klipping, C
    Gerlinger, C
    Ruebig, A
    Schmidt, W
    Holler, T
    Düsterberg, B
    [J]. CONTRACEPTION, 2001, 64 (04) : 235 - 241
  • [9] Comparison of a 24-day and a 21-day pill regimen for the novel combined oral contraceptive, nomegestrol acetate and 17β-estradiol (NOMAC/E2): a double-blind, randomized study
    Christin-Maitre, S.
    Serfaty, D.
    Chabbert-Buffet, N.
    Ochsenbein, E.
    Chassard, D.
    Thomas, J. -L.
    [J]. HUMAN REPRODUCTION, 2011, 26 (06) : 1338 - 1347
  • [10] The Risk of VTE in Users of a 24-Day Regimen of a Combined Oral Contraceptive Compared to Conventional 21-Day OC Regimens: Results from the INAS-OC Study
    Dinger, Juergen
    Bardenheuer, Kristina
    Franke, Christian
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S131 - S131
1234